Viavi Solutions slides as investors appear to de-risk ahead of upcoming earnings despite fresh PCIe 7.0 product update

Viavi Solutions Inc. (VIAV) is down 6.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The day’s decline appears more consistent with pre-earnings positioning and profit-taking than with a single negative headline. While the company released a technology-focused update this morning, it did not include new financial results, and investors may be waiting for the upcoming quarterly report.

Details:

The company announced an investment in a new PCIe 7.0 protocol analysis testing platform under its Xgig product family, with an initial showcase planned for May 6–7 at an industry developer conference.

The company is scheduled to report fiscal third-quarter 2026 results after the market close on Wednesday, April 29, 2026, with a same-day earnings call.

In its prior quarterly release, the company provided fiscal third-quarter outlook ranges (including revenue and non-GAAP EPS), which may be driving near-term expectations and volatility into the print.

This could also reflect short-term “sell-the-news” trading after a strong run into late April, as investors reduce exposure ahead of an event-driven catalyst.

Sources:

PR Newswire, VIAVI Investor Relations, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$VIAV Insider Trading Activity

$VIAV insiders have traded $VIAV stock on the open market 45 times in the past 6 months. Of those trades, 0 have been purchases and 45 have been sales.

Here’s a breakdown of recent trading of $VIAV stock by insiders over the last 6 months:

OLEG KHAYKIN (President & CEO) has made 0 purchases and 14 sales selling 619,224 shares for an estimated $13,900,937.
KEITH BARNES has made 0 purchases and 4 sales selling 175,400 shares for an estimated $3,139,797.
ILAN DASKAL (EVP, CFO) has made 0 purchases and 3 sales selling 170,000 shares for an estimated $2,972,993.
GARY W STALEY (SVP Global Sales NSE) has made 0 purchases and 7 sales selling 90,069 shares for an estimated $2,289,155.
DONALD A COLVIN has made 0 purchases and 3 sales selling 65,000 shares for an estimated $1,414,357.
KEVIN CHRISTOPHER SIEBERT (SVP Gen. Counsel & Secretary) has made 0 purchases and 4 sales selling 56,214 shares for an estimated $1,236,939.
RICHARD BELLUZZO has made 0 purchases and 2 sales selling 28,833 shares for an estimated $768,942.
LUKE M SCRIVANICH (SVP General Manager OSP) has made 0 purchases and 2 sales selling 23,666 shares for an estimated $540,026.
PAUL MCNAB (EVP, Chief Mktg & Stgy Officer) has made 0 purchases and 4 sales selling 22,463 shares for an estimated $486,172.
RICHARD JOHN BURNS sold 3,384 shares for an estimated $63,483
EUGENIA CORRALES sold 3,384 shares for an estimated $63,483

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

EARLY ACCESS

Receive VIAV Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$VIAV Hedge Fund Activity

We have seen 225 institutional investors add shares of $VIAV stock to their portfolio, and 175 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 7,888,249 shares (-70.3%) from their portfolio in Q4 2025, for an estimated $140,568,597
WOODLINE PARTNERS LP removed 4,438,187 shares (-88.7%) from their portfolio in Q4 2025, for an estimated $79,088,492
WELLINGTON MANAGEMENT GROUP LLP removed 3,415,517 shares (-23.7%) from their portfolio in Q4 2025, for an estimated $60,864,512
PARSIFAL CAPITAL MANAGEMENT, LP added 3,385,700 shares (+inf%) to their portfolio in Q4 2025, for an estimated $60,333,174
POINT72 ASSET MANAGEMENT, L.P. removed 3,210,605 shares (-78.6%) from their portfolio in Q4 2025, for an estimated $57,212,981
AMERIPRISE FINANCIAL INC added 2,184,183 shares (+139.1%) to their portfolio in Q4 2025, for an estimated $38,922,141
INVESCO LTD. added 2,045,702 shares (+116.0%) to their portfolio in Q4 2025, for an estimated $36,454,409

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$VIAV Congressional Stock Trading

Members of Congress have traded $VIAV stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $VIAV stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 03/27, 03/09, 11/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

$VIAV Analyst Ratings

Wall Street analysts have issued reports on $VIAV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 01/29/2026
Stifel issued a "Buy" rating on 12/17/2025

To track analyst ratings and price targets for $VIAV, check out Quiver Quantitative's $VIAV forecast page.

$VIAV Price Targets

Multiple analysts have issued price targets for $VIAV recently. We have seen 7 analysts offer price targets for $VIAV in the last 6 months, with a median target of $25.0.

Here are some recent targets:

Dave Kang from B. Riley Securities set a target price of $53.0 on 04/24/2026
Mike Genovese from Rosenblatt set a target price of $42.0 on 03/18/2026
Ryan Koontz from Needham set a target price of $36.0 on 03/02/2026
Ruben Roy from Stifel set a target price of $24.0 on 01/29/2026
Mehdi Hosseini from Susquehanna set a target price of $25.0 on 01/29/2026
Jim Kelleher from Argus Research set a target price of $23.0 on 11/05/2025
Andrew Spinola from UBS set a target price of $17.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.